Search

everythinglearnresearchcommunity

for

Search:↓

The treatment showed significant hair regrowth in alopecia areata patients without side effects.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Topical tofacitinib may effectively and safely regrow facial hair in some people with alopecia areata.

Tofacitinib helped a person with total body hair loss grow hair again without bad side effects.

Tofacitinib can regrow hair in alopecia areata patients, but some may experience flares during treatment.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Tofacitinib effectively regrows hair in alopecia areata but may need continuous use.

Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.

A child with trichothiodystrophy also had autoimmune thyroiditis and anemia, which is a new finding.

Topical tofacitinib is effective and safe for treating alopecia areata.

The LTF gene may help predict and manage nonspecific orbital inflammation.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Tofacitinib helped an 8-year-old child recover from a type of hair loss that is hard to treat.

Tofacitinib is a promising treatment for children with rheumatic diseases.

A 3-year-old boy was diagnosed with a rare, non-scarring hair loss condition called temporal triangular alopecia.

A deep learning model was developed to help diagnose trichothiodystrophy by analyzing hair patterns.

Tofacitinib therapy can effectively regrow eyebrows and eyelashes in some alopecia areata patients.

AI and new therapies show promise in medicine, especially for cancer and regenerative treatments.

Ritlecitinib may help treat alopecia areata by protecting hair follicles.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

AI-09 is safe, effective, and reduces wrinkles for up to 6 months.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib is effective for severe alopecia areata, similar to oral betamethasone.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.